Cardiac drug toxicity: digitalis glycosides and calcium-channel and beta-blocking agents.

The Medical Journal of Australia
P R Pentel, D M Salerno


No abstract listed.


Dec 1, 1979·Annals of Internal Medicine·A BuiumsohnW H Frishman
Sep 1, 1986·Journal of Cardiovascular Pharmacology·F A JonkmanP A van Zwieten
Jul 1, 1985·The American Journal of Emergency Medicine·M HenryP Viccellio
Oct 1, 1985·Journal of Clinical Pharmacology·J C Somberg
Nov 1, 1985·Acta Pharmacologica Et Toxicologica·J LangemeijerB Sangster
May 1, 1987·Clinical Pharmacokinetics·J G RiddellR G Shanks
Jun 1, 1986·The Journal of Clinical Investigation·R GayS Goldman
Jul 1, 1987·Medical Toxicology and Adverse Drug Experience·F T Fraunfelder, S M Meyer
Jan 1, 1987·Drugs·B EdgarC G Regårdh
Jan 1, 1987·Drugs·B Ljung, M Nordlander
Dec 1, 1987·Journal of Clinical Pharmacology·M AndrejakJ P Lesbre
Oct 1, 1987·The American Journal of Cardiology·A T Jakubowski, H F Mizgala
Jun 1, 1986·Annals of Internal Medicine·R B StewartH L Greene
Aug 1, 1986·The American Journal of Medicine·D M HerringtonG G Weinmann
Oct 1, 1986·Annals of Emergency Medicine·S W Snover, V Bocchino
Mar 1, 1986·Medical Toxicology·P R Pentel, N L Benowitz
Jan 1, 1987·Annals of Emergency Medicine·G J OrdogS Balasubramanium
May 1, 1985·Journal of the American College of Cardiology·T L WengerT W Smith
Oct 1, 1985·Journal of Clinical Pharmacology·J T Bigger
Feb 1, 1985·Critical Care Medicine·T J IbertiE Benjamin
Apr 1, 1985·Clinical Pharmacology and Therapeutics·R L LalondeD C Greenway
May 1, 1985·Clinical Pharmacology and Therapeutics·P R PentelN L Benowitz
Jan 1, 1985·Acta Medica Scandinavica·K E PedersenS Hvidt
Dec 1, 1985·Drug Intelligence & Clinical Pharmacy·G D ParkP Roberts
Apr 1, 1970·American Heart Journal·G T NolaD C Harrison
Jun 5, 1971·The Medical Journal of Australia·P Thorpe
Sep 30, 1971·The New England Journal of Medicine·W W Parmley
Jan 1, 1984·British Journal of Clinical Pharmacology·J H SilasH F Woods
Dec 1, 1984·Annals of Emergency Medicine·R S Weinstein
Nov 1, 1984·The American Journal of Emergency Medicine·A Heath
Jan 1, 1983·European Heart Journal·E Erdmann, L Brown
Mar 1, 1983·Clinical Pharmacokinetics·B Fichtl, W Doering
Dec 1, 1983·Journal of the American College of Cardiology·J J EnyeartL Woods
Dec 1, 1984·Journal of the American College of Cardiology·A KaoD G Benditt

❮ Previous
Next ❯


Aug 28, 1999·Journal of Toxicology. Clinical Toxicology·K D DonovanJ F Dreyer
Jun 1, 1996·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·T Van VoorstD McGee
Jan 1, 1996·The Annals of Pharmacotherapy·D T Chin
Dec 1, 1996·Zentralblatt für Veterinärmedizin. Reihe A·A OryanM Maleki

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Practitioner
A M Breckenridge, M L Orme
Deutsche medizinische Wochenschrift
W Kübler
Deutsche medizinische Wochenschrift
H Hochrein
© 2021 Meta ULC. All rights reserved